PP
INSY

PDT Partners’s Insys Therapeutics, Inc. INSY Stock Holding History

PDT Partners’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-243,628
Closed -$8.75M – 1712
2015
Q2 		$8.75M Buy
243,628
+219,808
+923% +$6.85M 0.23% 95
2015
Q1 		$692K Buy
+23,820
New +$630K 0.02% 907
2014
Q4 		– Sell
-27,470
Closed -$533K – 1242
2014
Q3 		$533K Sell
27,470
-332,516
-92% -$5.22M 0.01% 919
2014
Q2 		$5.62M Buy
359,986
+236,200
+191% +$3.82M 0.15% 167
2014
Q1 		$2.56M Buy
123,786
+33,672
+37% +$668K 0.06% 385
2013
Q4 		$1.16M Sell
90,114
-67,083
-43% -$930K 0.14% 214
2013
Q3 		$1.83M Buy
+157,197
New +$1.29M 0.05% 524

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PDT Partners's INSY Position: Q3 2015 in Review

PDT Partners sold out of Insys Therapeutics, Inc. (INSY) in Q3 2015, closing a stake of 243,628 shares — an estimated $8.75M sold.

PDT Partners first reported a position in INSY in Q3 2013 and held it in 7 quarters. The position peaked at $8.75M in Q2 2015. 145 funds tracked by Wall St. Rank hold INSY as of Q3 2015.

  • PDT Partners reported no remaining Insys Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • PDT Partners sold 243,628 Insys Therapeutics, Inc. shares in Q3 2015, an estimated $8.75M.
  • PDT Partners first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 7 quarters.
  • PDT Partners's Insys Therapeutics, Inc. position peaked at $8.75M in Q2 2015.
  • 145 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2015.

Based on PDT Partners's 13F filing for Q3 2015, filed 16 Nov 2015.